Research programme: BIRC3 protein inhibitors - Pharmascience

Drug Profile

Research programme: BIRC3 protein inhibitors - Pharmascience

Alternative Names: AEG 3373; BIRC3 antisense therapy; HIAP-1 antisense therapy; HIAP-1 inhibitors

Latest Information Update: 05 Mar 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Aegera Therapeutics
  • Class
  • Mechanism of Action Apoptosis stimulants; BIRC3 protein inhibitors; Inhibitor of apoptosis protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Cancer

Most Recent Events

  • 05 Mar 2007 Discontinued - Preclinical for Cancer in Canada (Parenteral)
  • 18 Nov 2004 Preclinical development is ongoing
  • 26 Aug 2003 Preclinical trials in Cancer in Canada (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top